Combogesic Tablet, Film Coated
Product Images NDC 0143-9432

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Combogesic (NDC 0143-9432). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Combogesic 01)

Chemical structure of the active ingredient shown in the image, which is Acetaminophen. The structure includes a benzene ring with hydroxyl and amide functional groups.*

FDA Label Image

Chemical Structure (Combogesic 02)

Chemical structure diagram of the active ingredient ibuprofen, illustrating its molecular framework with characteristic functional groups and bonds as depicted in the image.*

FDA Label Image

Figure 1 (Combogesic 03)

A line graph depicting pain intensity difference (mm) over time (hours) for four groups: Combogesic, Ibuprofen, Acetaminophen, and Placebo. The graph shows pain intensity differences measured from 0 to 6 hours, with Combogesic group exhibiting the highest pain intensity difference throughout the time period compared to the other groups.*

FDA Label Image

Principal Display Panel (325 mg/97.5 mg Tablet Bottle Label)

Label for Combogesic tablets containing acetaminophen 325 mg and ibuprofen 97.5 mg. The label indicates the product is an oral film-coated tablet with a package size of 250 tablets. The manufacturer is Catalent Greenville Inc., and the product is distributed by Hikma Pharmaceuticals USA Inc. The label includes storage instructions and a warning to keep out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.